Shares of Glenmark on Friday registered its biggest intraday fall in seven years, here the stock plunging as much as 14 percent, a day after the company reported lower than expected Q4 numbers.
Sequentially US sales dropped 23 percent to Rs. Glenmark reported its click href="/prazosin-hcl-uses-capsules.html">learn more here ever results in December quarter with record net profit of Rs.
The company launched the drug in Generic zetia in US market, through its partner Par Pharmaceutical, a subsidiary Irish drugmaker Endo, under profit-sharing agreement.
The company too projected generic Zetia to bring in an glenmark pharmaceuticals windfall in the range of USD to million during glenmark pharmaceuticals generic zetia release date date exclusivity period.
However click here management revised guidance on Friday indicating that the sales of generic Zetia may well fall short of USD million mark, driving the shareholders into selling mode.
Merck holding on zetia release Zetia could be bad date for Glenmark because the company is banking on the drug to boost its cash flow. Analysts also worry about an imminent slowdown of US glenmark pharmaceuticals generic post the end of exclusivity of Zetia, if not backed by new approvals.
Like many other Indian generic drugmakers, Glenmark too is facing date pressure due consolidation glenmark pharmaceuticals generic zetia release date distribution channels and the rising competition.
In the fourth quarter alone, the company saw 15 percent price erosion of its base business. It expects price erosion to be in the range of percent in the current financial year. Reproduction of news articles, photos, videos or any other content source whole or in part in glenmark pharmaceuticals glenmark pharmaceuticals generic zetia release date zetia release date form or medium without express writtern permission of moneycontrol.
May 12, In pics Assembly Elections Final tally for all five states.
Here are the issues that RBI guv had with government. Glenmark falters on generic Zetia losing steam midway through Opposition-ruled states oppose rate cuts glenmark pharmaceuticals generic zetia release date revenue consideration.
Mumbai, India; December 12, The availability of ezetimibe is the result of a licensing partnership with Par Pharmaceutical, an Endo International plc operating company, with whom Glenmark will share profits.
Never miss a great news story! Get instant notifications from Economic Times Allow Not now. Launch of gZetia positively impacted US business:
Zetia is a brand name of ezetimibe , approved by the FDA in the following formulation s:. A generic version of Zetia has been approved by the FDA.
2018 ©